Effects of sulphite supplementation on vascular responsiveness in sulphite oxidase-deficient rats.
1. The aim of the present study was to explore the effect of dietary sulphite supplementation on vascular responsiveness in sulphite oxidase (SO)-deficient rats. 2. Male albino rats were divided into four groups, namely control (n = 8), sulphite-treated (n = 8), SO-deficient (n = 8) and sulphite-treated SO-deficient (n = 8) groups. Sulphite oxidase deficiency was induced by administration of a low-molybdenum diet with concurrent addition of 200 p.p.m. tungsten in the form of sodium tungstate in the drinking water for 9 weeks. Sulphite, in the form of sodium metabisulphite (Na(2)O(5)S(2); 25 mg/kg) was given in the drinking water to sulphite-treated and sulphite-treated SO-deficient groups for the last 6 weeks. The vascular responsiveness of isolated aortic rings to acetylcholine (ACh), sodium nitroprusside (SNP) and histamine was investigated in organ baths. 3. The responsiveness of aortic rings to SNP and histamine did not differ significantly between groups. Conversely, there was a significant decrease in ACh-induced relaxation in aortic rings from the sulphite-treated SO-deficient group compared with the control group (pD(2) 6.2 +/- 0.3 and 7.5 +/- 0.1, respectively; P < 0.05). Incubation of aortic rings in the presence of either l-arginine or superoxide dismutase significantly improved the ACh-induced vasorelaxation in sulphite-treated SO-deficient group (pD(2) 7.2 +/- 0.3 and 7.4 +/- 0.3, respectively). 4. The findings of the present study suggest that the increased production of reactive oxygen species and the resultant increment in l-arginine/nitric oxideconsumption may play a role in the reduced endothelium-dependent vasorelaxation in sulphite-treated SO-deficient rats.
Nacitarhan
Cahit
C
Department of Pharmacology, Faculty of Medicine, Akdeniz University, Antalya, Turkey. cahitnt@akdeniz.edu.tr
Kucukatay
Vural
V
Sadan
Gulay
G
Ozturk
Oktay Hasan
OH
Agar
Aysel
A
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001011:Aorta; D004032:Diet; D019587:Dietary Supplements; D006632:Histamine / Q000494:pharmacology; D008297:Male; D009599:Nitroprusside / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D050876:Sulfite Oxidase / Q000172:deficiency* / Q000378:metabolism*; D013447:Sulfites / Q000494:pharmacology*; D017973:Tungsten Compounds / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects*
D013447:Sulfites; D017973:Tungsten Compounds; D009599:Nitroprusside; C025399:sodium tungstate(VI); D006632:Histamine; D050876:Sulfite Oxidase; D000109:Acetylcholine